Schedule 13D ownership disclosure

Whitehawk Therapeutics, Inc.

Common stock, par value $0.0001 per share · CUSIP: 00032Q104

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BML Investment Partners, L.P.Reported CIK 0001373604

    Shares: 2,100,000 · Class: 8.5%

  • Leonard Braden MichaelReported CIK 0001373603

    Shares: 2,435,000 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001373604-24-000118
Form type
SCHEDULE 13D
Filer
Whitehawk Therapeutics, Inc.
CIK
CIK 1422142
Filed
Dec 31, 2024
Reporting period
Dec 31, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub